国際学会発表
米国血液学会(ASH)
2019年
永田啓人先生
Weight adjusted urinary creatinine excretion predicts transplant outcomes in adult patients with acute myeloid leukemia in complete remission.
小西達也先生
Clinical and Genetic Characteristics of Adolescent and Young Adult Patients with Myelodysplastic Syndromes
2018年
海渡智史先生
Combining the number of infectious episodes and interval of chemotherapy to transplantation may predict transplant outcomes in patients with AML: A retrospective analysis of JALSG AML201 study
2017年
海渡智史先生
Post-Transplant Maintenance Therapy with Azacitidine and Gemtuzumab Ozogamicin for High-Risk Hematologic Malignancies
2016年
黒澤修兵先生
Clinical Impact of Pre-Transplant Microbial Diversity on Transplant Outcomes
原田介斗先生
Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia Harboring t(7;11)(p15;p15)
2014年
池川俊太郎先生
Clinical impact of CD25 expression on the outcomes of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in relapse or primary induction failure.
新谷直樹先生
An Increase in Baseline Level of Urinary Liver-Type Fatty Acid-Binding Protein Linked with Poor Prognosis after Allogeneic Hematopoietic Stem Cell Transplantation
国際神経学会
2017年
黒澤修兵先生
Peripheral nerve injury following allogeneic hematopoietic stem cell transplantation
Society of hematologic oncology（SOHO)
2016年
原田介斗先生
Clinical impact of underweight on the outcome of patients with acute myeloid leukemia: Retrospective study of JALSG AML201
受賞
日本血液学会 第81回学術集会 優秀ポスター賞
小西 達矢先生 「同種造血幹細胞移植後患者における侵襲性肺炎球菌感染症の臨床的特徴」
造血細胞移植学会 第39回日本造血細胞移植学会総会奨励賞
黒澤修兵先生 「同種造血幹細胞移植前における腸内細菌叢の多様性と移植成績の検討」
日本血液学会 第9回関東甲信越地方会 優秀演題
和田 敦司先生 「良好な経過を辿ったt(6;21;8)(p23;q22;22)を有する急性骨髄性白血病の1例」
日本血液学会 第7回関東甲信越地方会 奨励賞
小西 達矢先生 「臍帯血移植により著明に改善した難治性薬剤性過敏症候群(DIHS)」
日本血液学会 第6回関東甲信越地方会 奨励賞
永田 啓人先生 「白血化した PDGFRB 遺伝子の再構成を伴った骨髄系及びリンパ系腫瘍の 1 例」
日本血液学会 第1回関東甲信越地方会 優秀演題
山口 津加彩先生 「白血病診断時に偶然発見されたRobertson型転座の1例」
国際誌
2023年（4月時点）
Sakaguchi M, Atsuta Y, Sekiya N, et al. Clinical impact and early prediction of carbapenem-resistant Pseudomonas aeruginosa bacteraemia in allogeneic hematopoietic stem cell transplantation recipients. J Glob Antimicrob Resist. 2023 Mar;32:187-194.
Konishi T, Sadato D, Toya T, et al. Impact of gene alterations on clinical outcome in young adults with myelodysplastic syndromes. Sci Rep. 2023 Feb 14;13(1):2641.
Ogawa H, Konishi T, Najima Y, et al. Phase I trial of myeloablative conditioning with 3-day total marrow and lymphoid irradiation for leukemia. Cancer Sci. 2023 Feb;114(2):596-605.
2022年
Konishi T, Ogawa H, Najima Y, et al. Outcomes of allogeneic haematopoietic stem cell transplantation with intensity-modulated total body irradiation by helical tomotherapy: a 2-year prospective follow-up study. Ann Med. 2022 Dec;54(1):2617-2626.
Nagata A, Otsuka Y, Konuma R, et al. Weight-adjusted urinary creatinine excretion predicts transplant outcomes in adult patients with acute myeloid leukemia in complete remission. Leuk Lymphoma. 2022 Dec;63(13):3117-3127.
Kishida Y, Shingai N, Hara K, et al. Impact of lung function impairment after allogeneic hematopoietic stem cell transplantation. Sci Rep. 2022 Aug 19;12(1):14155.
Kishida Y, Shingai N, Nakao S, st al. Late-onset refractory autoimmune hemolytic anemia following hematologic recovery after allo-HSCT in aplastic anemia-PNH syndrome. Rinsho Ketsueki. 2022;63(5):347-352.
Wada A, Doki N, Otsuka Y, et al. A favorable clinical course of acute myeloid leukemia with t (6;21;8)(p23;q22;q22). Rinsho Ketsueki. 2022;63(2):104-107.
Yamada Y, Konishi T, Nagata A, et al. Very low-dose antithymocyte globulin (thymoglobulin) is effective for steroid-refractory acute graft-versus-host disease involving the skin or gut after allogeneic hematopoietic stem cell transplantation.
Int J Hematol. 2022 Mar;115(3):449-451.
Yamada Y, Ikegawa S, Najima Y, et al. Retrospective comparison of hematopoietic stem cell transplantation following reduced-intensity conditioning with fludarabine/low-dose melphalan plus 4 Gy TBI versus fludarabine/ busulfan plus 4 Gy TBI. Int J Hematol. 2022 Feb;115(2):244-254.
2021年
Adachi H, Sadato D, Toya T, et al. Donor-derived gene mutations in sex chromosome loss after stem cell transplantation. Br J Haematol. 2021 Nov;195(3):e142-e146.
Kurosawa S, Toya T, Sadato D, et al. Mutation profiles of diffuse large B-cell lymphoma transformation of splenic B-cell lymphoma/leukemia, unclassifiable on whole-exome sequencing. eJHaem. 2021 Nov;2(4): 854-860.
Yamamoto K, Najima Y, Iizuka H, et al. Successful Cord Blood Transplantation for Idiopathic CD4+ Lymphocytopenia. Acta Haematol. 2021;144(6):698-705.
Kurosawa S, Kaito S, Uchida N, et al. Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia with high hyperdiploidy: a retrospective nationwide study. Leuk Lymphoma. 2021 Oct;62(10):2514-2520.
Adachi H, Sekiya N, Kambara Y, et al. Clinical features of tuberculosis among allogeneic hematopoietic stem cell transplantation recipients. Rinsho Ketsueki. 2021;62(4):239-244.
Konishi T, Sekiya N, Otsuka Y, et al. Changes in vaccination strategies contribute to the development of invasive pneumococcal disease in allogeneic hematopoietic stem cell transplantation recipients: a retrospective study for promoting vaccination. Int J Hematol. 2021 Aug;114(2):263-270.
Konishi T, Kusakabe S, Hino A, et al. Low diversity of gut microbiota in the early phase of post-bone marrow transplantation increases the risk of chronic graft-versus-host disease. Bone Marrow Transplant. 2021 Jul;56(7):1728-1731.
Atsuta Y, Doki N. Hematopoietic stem cell transplantation during the COVID-19 pandemic with reference to EBMT recommendation. Rinsho Ketsueki. 2021;62(2):106-114.
2020年
Adachi H, Najima Y, Konishi T, et al. Intraventricular rupture of Aspergillus brain abscess during remission induction. Int J Infect Dis. 2020 Dec;101:346-347.
Konishi T, Ogawa H, Najima Y, et al. Safety of total body irradiation using intensity-modulated radiation therapy by helical tomotherapy in allogeneic hematopoietic stem cell transplantation: a prospective pilot study. J Radiat Res. 2020 Nov 16;61(6):969-976.
Kaito S, Wada A, Adachi H, et al. Geriatric nutritional risk index as a useful prognostic factor in second allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2020 Jul;99(7):1655-1665.
Nagata A, Sekiya N, Najima Y, et al. Nontuberculous mycobacterial bloodstream infections after allogeneic hematopoietic stem cell transplantation. Int J Infect Dis. 2020 Aug;97:131-134.
Kurosawa S, Doki N, Senoo Y, et al. Bone turnover markers as an aid to monitor osteoporosis following allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2020 Aug;99(8):1873-1882.
Kaito S, Najima Y, Harada K, et al. Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia harboring t(1;19)(q23;p13.3); comparison with normal karyotype. Bone Marrow Transplant. 2020 Jul;55(7):1337-1346.
Kaito S, Sekiya N, Najima Y, et al. Nutritional risk index as a risk factor for breakthrough candidemia in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2020 Mar;55(3):661-664.
Konishi T, Motoi T, Kakihana K. Unusual megakaryocyte aggregation mimicking bone marrow carcinomatosis. Int J Hematol. 2020 Mar;111(3):325-326.
Nagata A, Doki N, Harada H, et al. Late appearance of eosinophilia in myeloid blast phase of myeloid neoplasm with rearrangement of PDGFRβ. Leuk Lymphoma. 2020 Feb 26:1-4.
Konishi T, Doki N, Nagata A, et al. Unmanipulated haploidentical hematopoietic stem cell transplantation using very low-dose antithymocyte globulin and methylprednisolone in adults with relapsed/refractory acute leukemia. Ann Hematol. 2020 Jan;99(1):147-155.
2019年
Kurosawa S, Sekiya N, Doki N, et al. The emergence of rare nocardiosis following allogeneic hematopoietic stem cell transplantation in the era of molecular taxonomy. Int J Infect Dis. 2019 Dec;89:154-162
Konishi T, Muto H, Sakuma R, et al. Familial case of hereditary Pelger-Huët anomaly. Int J Hematol. 2019 Aug;110(2):127-128.
Konishi T, Doki N, Kishida Y, et al. Geriatric nutritional risk index (GNRI) just before allogeneic hematopoietic stem cell transplantation predicts transplant outcomes in patients older than 50 years with acute myeloid leukemia in complete remission. Ann Hematol. 2019 Jul;98(7):1799-1801
Adachi H, Doki N, Hino Y, et al. Transfusion-associated circulatory overload with pulmonary alveolar hemorrhage following allogeneic bone marrow transplantation. Rinsho Ketsueki. 2019;60(4):296-301.
Kaito S, Doki N, Hishima T, Takaki Y, Ohashi K. Progressive Hepatic Cirrhosis Early After Allogeneic Hematopoietic Stem Cell Transplantation in a Patient with Chronic Hepatitis C Infection. Turk J Haematol. 2019 May 3;36(2):130-133.
Shingai N, Kaito S, Yamada Y, et al. Reassessment of clinical implication of pretransplant surgical procedures for pulmonary invasive fungal lesions. Transpl Infect Dis. 2019 Feb;21(1):e13023.
Konishi T, Doki N, Takaki Y, Igarashi A, Ohashi K. Presacral extramedullary hematopoiesis under treatment with an erythropoietin-stimulating agent for myelodysplasia. Int J Hematol. 2019 Jan;109(1):1-2.
2018年
Kurosawa S, Toya T, Kishida Y, et al. Outcome of patients with acute undifferentiated leukemia after allogeneic hematopoietic stem cell transplantation. Leuk Lymphoma. 2018 Dec;59(12):3006-3009.
Kaito S, Toya T, Yoshifuji K, et al. Fecal microbiota transplantation with frozen capsules for a patient with refractory acute gut graft-versus-host disease. Blood Adv. 2018 Nov 27;2(22):3097-3101.
Harada K, Doki N, Miyazaki Y, et al. Clinical impact of underweight status at diagnosis on elderly patients with acute myeloid leukemia: a retrospective study of JALSG GML200. Ann Hematol. 2018 Aug;97(8):1481-1483.
Harada K, Doki N, Aoki J, et al. Outcomes after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia harboring t(7;11)(p15;p15). Haematologica. 2018 Feb;103(2):e69-e72.
Harada K, Doki N, Hagino T, et al. Underweight status at diagnosis is associated with poorer outcomes in adult patients with acute myeloid leukemia: a retrospective study of JALSG AML 201. Ann Hematol. 2018 Jan;97(1):73-81.
- 2017年以前
2017年
Kurosawa S, Sekiya N, Muraosa Y, et al. Disseminated fusariosis in patients with acute leukemia: a retrospective analysis of three cases. Rinsho Ketsueki. 2017;58(12):2375-2379.
Kurosawa S, Doki N, Sekiya N, Ikuta S, Takaki Y, Ohashi K. Sudden blindness as an initial manifestation of localized fusariosis in ethmoid sinus and optic nerve. Ann Hematol. 2017 Oct;96(10):1771-1772.
Harada K, Sekiya N, Konishi T, et al. Predictive implications of albumin and C-reactive protein for progression to pneumonia and poor prognosis in Stenotrophomonas maltophilia bacteremia following allogeneic hematopoietic stem cell transplantation. BMC Infect Dis. 2017 Sep 22;17(1):638.
Yoshioka K, Kakihana K, Doki N, Ohashi K. Gut microbiota and acute graft-versus-host disease. Pharmacol Res. 2017 Aug;122:90-95.
Hino Y, Doki N, Kurosawa S, Yamamoto K, et al. Erythrocytosis after allogeneic hematopoietic stem cell transplantation. Clin Transplant. 2017 Apr;31(4).
Kurosawa S, Doki N, Sekiya N, et al. Pyomyositis caused by Streptococcus pneumoniae after allogeneic hematopoietic stem cell transplantation. J Infect Chemother. 2017 Apr;23(4):250-252.
Ikegawa S, Doki N, Kaito S, et al. Central Nervous System Involvement at the Time of Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with a Poor Outcome in Patients with Acute Myeloid Leukemia. Pathol Oncol Res. 2017 Apr;23(2):433-437.
Hanajiri R, Kobayashi T, Yoshioka K, et al. Central nervous system infection following allogeneic hematopoietic stem cell transplantation. Hematol Oncol Stem Cell Ther. 2017 Mar;10(1):22-28.
2016年
Harada K, Yamada Y, Konishi T, et al. Comparison of transplant outcomes and economic costs between biosimilar and originator filgrastim in allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2016 Dec;104(6):709-719.
Hino Y, Doki N, Senoo Y, et al. Disseminated nocardiosis after unrelated bone marrow transplantation. Transpl Infect Dis. 2016 Dec;18(6):942-945.
Ikegawa S, Najima Y, Sano N, et al. Donor cell leukemia with bone marrow necrosis. Rinsho Ketsueki. 2016;57(11):2334-2338.
Yamamoto K, Doki N, Senoo Y, et al. Severe Hypoxemia in a Healthy Donor for Allogeneic Hematopoietic Stem Cell Transplantation after Only the First Administration of Granulocyte-Colony Stimulating Factor. Transfus Med Hemother. 2016 Nov;43(6):433-435.
Hino Y, Doki N, Yamamoto K, et al. Chronic myeloid leukemia relapsing ten years after allogenic bone marrow transplantation. Rinsho Ketsueki. 2016 May;57(5):608-12.
Harada K, Kurosawa S, Hino Y, et al. Clinical utility of high-flow nasal cannula oxygen therapy for acute respiratory failure in patients with hematological disease. Springerplus. 2016 Apr 23;5:512.
Kurosawa S, Doki N, Kaito S, et al. Chronic myelogenous leukemia initially presenting with multiple subcutaneous tumors due to extramedullary hematopoiesis. Rinsho Ketsueki. 2016 Apr;57(4):461-6.
Hino Y, Doki N, Sekiya N, Takaki Y, Ohashi K. Optic neuritis as an initial manifestation of human herpesvirus 6 reactivation after unrelated bone marrow transplantation. Br J Haematol. 2016 Mar;172(5):654.
Kurosawa S, Doki N, Hino Y, et al. Occurrence of Donor Cell-derived Lymphoid Blast Crisis 24 Years Following Related Bone Marrow Transplantation for Chronic Myeloid Leukemia. Intern Med. 2016;55(4):395-7.
Ikegawa S, Doki N, Kurosawa S, et al. CD25 expression on residual leukemic blasts at the time of allogeneic hematopoietic stem cell transplant predicts relapse in patients with acute myeloid leukemia without complete remission. Leuk Lymphoma. 2016;57(6):1375-81.
Ikegawa S, Doki N, Kurosawa S, et al. Allogeneic hematopoietic stem cell transplant overcomes poor prognosis of acute myeloid leukemia with myelodysplasia-related changes. Leuk Lymphoma. 2016;57(1):76-80.
2015年
Shingai N, Morito T, Najima Y, et al. Early-onset acute kidney injury is a poor prognostic sign for allogeneic SCT recipients. Bone Marrow Transplant. 2015 Dec;50(12):1557-62.
Hanajiri R, Kakihana K, Kobayashi T, Doki N, Sakamaki H, Ohashi K. Tobacco smoking is associated with infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2015 Aug;50(8):1141-3.
Ikegawa S, Doki N, Yamamoto K, et al. Clinical impact of CD25 expression on outcomes of allogeneic hematopoietic stem cell transplant for cytogenetically intermediate-risk acute myeloid leukemia. Leuk Lymphoma. 2015 Jun;56(6):1874-7.
2014年
Shingai N, Morito T, Najima Y, et al. Urinary liver-type fatty acid-binding protein linked with increased risk of acute kidney injury after allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2014 Dec;20(12):2010-4.
Yamamoto K, Doki N, Oshikawa G, et al. Development of aggressive T-cell leukemia at 1 month after the diagnosis of hypereosinophilic syndrome. Leuk Lymphoma. 2014 Oct;55(10):2402-4.
Aoki J, Tsubokura M, Kakihana K, et al. The predictive value for pulmonary infection by area over the neutrophil curve (D-index) in patients who underwent reduced intensity hematopoietic stem cell transplantation. Pathol Oncol Res. 2014 Oct;20(4):879-83.
Shingai N, Kakihana K, Oshikawa G, et al. Clinical impact of pre-transplant diastolic function on outcome after allogeneic hematopoietic SCT. Bone Marrow Transplant. 2014 Sep;49(9):1241-3.
Aoki J, Ohashi K, Mitsuhashi M, et al. Posttransplantation bone marrow assessment by quantifying hematopoietic cell-derived mRNAs in plasma exosomes/microvesicles. Clin Chem. 2014 Apr;60(4):675-82.
Shingai N, Taniguchi K, Kakihana K. Neutropenia associated with antihuman neutrophil antibodies following allogeneic hematopoietic stem cell transplantation. Transpl Int. 2014 Mar;27(3):e21-3.